Lv4
407 积分 2024-09-01 加入
Intra- and Peritumoral CT-Based Radiomics for Assessing Pathologic T-Staging in Clear Cell Renal Cell Carcinoma: A Multicenter Study
1天前
已完结
Foundation Model and Radiomics-Based Quantitative Characterization of Perirenal Fat in Renal Cell Carcinoma Surgery
1天前
求助中
Cabozantinib plus Nivolumab and Ipilimumab in Renal-Cell Carcinoma
13天前
已完结
Optimization of Immunotherapy-Based Combinations for Metastatic Renal Cell Carcinoma: A Network Meta-Analysis
16天前
已完结
First‐line immunotherapy of metastatic renal cell carcinoma: an updated network meta‐analysis including triplet therapy
16天前
已完结
Health-related quality of life for immediate versus delayed androgen-deprivation therapy in patients with asymptomatic, non-curable prostate cancer (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial
18天前
已完结
Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer
18天前
已完结
Systemic Treatment for Biochemical Recurrence of Localized Prostate Cancer: Do Not EMBARK on When, If the Answer Is How
18天前
已完结
The clinicopathological characteristics and prognosis of 55 patients with TFE3-rearranged renal cell carcinomas
18天前
已完结
Real-World Primary Resistance to First-Line Immune-Based Combinations in Patients with Advanced Renal Cell Carcinoma (ARON-1)
18天前
已完结
皖公网安备34019202002308
